Literature DB >> 3162360

Effect of protein binding on drug penetration into blister fluid.

W C Shyu1, R Quintiliani, C H Nightingale, M N Dudley.   

Abstract

The effect of protein binding on drug penetration into blister fluid was evaluated by using cefonicid, ceftizoxime, and cefotaxime. Drug concentrations in a chamber with a high surface area/volume ratio (i.e., paper disk) follow changes in serum more closely than do those in a chamber with a low surface area/volume ratio. Both the area under the concentration-time curve ratio and the concentration ratio (by the disk method) for cefonicid were statistically lower than the ratios for ceftizoxime and cefotaxime. The high degree of protein binding of cefonicid results in the availability of less drug for diffusion to blister fluid than with the low-protein-binding ceftizoxime and cefotaxime.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3162360      PMCID: PMC172112          DOI: 10.1128/AAC.32.1.128

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  The penetration of antibiotics into peritoneal fluid.

Authors:  D N Gerding; W H Hall
Journal:  Bull N Y Acad Med       Date:  1975-10

2.  Exudate levels and bactericidal activity of cefazolin in a new local infection system using rat granuloma pouches.

Authors:  M Nishida; T Murakawa
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

3.  An improved method to determine interstitial fluid pharmacokinetics.

Authors:  W C Shyu; R Quintiliani; C H Nightingale
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

4.  A method for measurement of antibiotics in human interstitial fluid.

Authors:  J S Tan; A Trott; J P Phair; C Watanakunakorn
Journal:  J Infect Dis       Date:  1972-11       Impact factor: 5.226

5.  Levels of carbenicillin, ticarcillin, cephalothin, cefazolin, cefamandole, gentamicin, tobramycin, and amikacin in human serum and interstitial fluid.

Authors:  J S Tan; S J Salstrom
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

6.  Effect of the ratio of surface area to volume on the penetration of antibiotics in to extravascular spaces in an in vitro model.

Authors:  L L Van Etta; L R Peterson; C E Fasching; D N Gerding
Journal:  J Infect Dis       Date:  1982-09       Impact factor: 5.226

7.  The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics.

Authors:  R Wise; A P Gillett; B Cadge; S R Durham; S Baker
Journal:  J Infect Dis       Date:  1980-07       Impact factor: 5.226

8.  Cephalosporin and aminoglycoside concentrations in peritoneal capsular fluid in rabbits.

Authors:  D N Gerding; W H Hall; E A Schierl; R E Manion
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

9.  Role of serum protein binding and multiple antibiotic doses in the extravascular distribution of ceftizoxime and cefotaxime.

Authors:  D N Gerding; L L Van Etta; L R Peterson
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

10.  Penetration of cefazolin, cephaloridine, and cefamandole into interstitial fluid in rabbits.

Authors:  C Carbon; A Contrepois; N Brion; S Lamotte-Barrillon
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

View more
  16 in total

1.  Pharmacokinetic profile of meropenem, administered at 500 milligrams every 8 hours, in plasma and cantharidin-induced skin blister fluid.

Authors:  Dana Maglio; Renli Teng; Per T Thyrum; Charles H Nightingale; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

Review 2.  Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response.

Authors:  D E Nix; S D Goodwin; C A Peloquin; D L Rotella; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

3.  Effect of protein binding in serum on therapeutic efficacy of cephem antibiotics.

Authors:  S Tawara; S Matsumoto; T Kamimura; S Goto
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

4.  Community-based parenteral anti-infective therapy (CoPAT). Pharmacokinetic and monitoring issues.

Authors:  D N Williams; J L Raymond
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

5.  Significance of "extravascular" protein binding for antimicrobial pharmacodynamics in an in vitro capillary model of infection.

Authors:  M N Dudley; J Blaser; D Gilbert; S H Zinner
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

Review 6.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

7.  Pharmacodynamic activity of a cephalosporin, Ro 40-6890, in human skin blister fluid: antibiotic activity in concert with host defense mechanisms.

Authors:  J F Hoogkamer; W H Hesse; S Sansano; W Zimmerli
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

8.  Human subcutaneous tissue distribution of fluconazole: comparison of microdialysis and suction blister techniques.

Authors:  Lucy Sasongko; Kenneth M Williams; Richard O Day; Andrew J McLachlan
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

9.  Penetration of antibiotics into the surgical wound in a canine model.

Authors:  E Rosin; S Ebert; T S Uphoff; M H Evans; N J Schultz-Darken
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

10.  Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteers.

Authors:  R Warlich; H C Korting; M Schäfer-Korting; E Mutschler
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.